# Struggling with stubborn cholesterol: There is good news from the US

> **Open Intelligence Dossier** · First detected: 2026-10-15 08:00 UTC · Category: Health

## Executive Summary
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Struggling with stubborn cholesterol: There is good news from the US&quot; is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Bioengineer.org, Futura, le média qui explore le monde, TipRanks and TCTMD.com. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Bioengineer.org | Cholesterol-Lowering Antibody Evolocumab Cuts Heart Attack Risk in Landmark Analysis | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxOa0F1a0xBOXJQMlB5NmppVmJZWElPUkZCVkdId2NnYWRFWnhTUnJYNDV2eTY0MHdET1hDODNrQzhqZ3hESUFjUF80aUd5OGFiV0otX1FWZXZpQnJyUFE2SzdJQ0dadmhjVmNaX3Z0NWtqMXB4Q1Q1LUVyOUV2YjRFVkNtbEc1bE1iV0thZko3eU9qZmxVbGR2YWY4Sl83UU5ZakhMemYtZjZXMTRfeHc?oc=5) |
| Futura, le média qui explore le monde | Doctors shocked: this new pill targets heart risk most treatments ignore | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxOeVBEck1PUmZ0c2otdU5CSy1oTTRYa2YyREpDVUpvUEg1dFhBalVqVWdQbnZkTG1pRU9seXQyOEg2cUlZVmxkZnR1YUZHRmxhbnlMTl9VdXVfbmFibG5WajhBaFdpM05YQkExNTRmQTBQdG5oMjNSRlZ6UFRvSml5bm54QXhXQXFPeU1GVWxTVmZaSE05TkhveDNJVXRrcGdDZjRmRWlWOWFQNWJtd1BQUEJRMA?oc=5) |
| TipRanks | AstraZeneca’s LAZURE Trial Signals Next Step in Cholesterol Treatment | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxQbGdqaV8xbXY0cXVRVnpMbTNOZVpaVHh1MjhLS0FqR2pnSUplcVJCWFFtb05xdmt0RHA1N1o5SnJ4dGRHWnBLLVhuNjRMcFI4TW4wX1IzbTFOV0swSVhCTmpRbkxfQTJ1V1pPX3JLb3A1UjM1a0ctUTdTOXRma3pqelZtTFFrRG9jam5RbC02NURHcEd4aGVRUF9reE9mRHF6VjRxMHVFeW5xSnJiTkpldDJ5Q2ZpOTBTR2lnSQ?oc=5) |
| TCTMD.com | Evolocumab Reduces MACE in Patients With Prior CABG But No MI: VESALIUS-CV | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxQRnRoajBrTkhuSFVmV3hwWHVLWUxXb3dFQ09FN0lGYklpNHo3S2owdlFFYUdRaGtuNEtvYlA4OWk3eUl5di1RSEVzcTlXWkw2N0F1YnNSTmJGd1FtenNOU1h1aHJMenpWSmZNLVJaVDlYQ09DX0h3b0xycDNtM3AyYmlrVWMzUFRLNGhkN2RGZE1hdw?oc=5) |
| The Times of India | Struggling with stubborn cholesterol: There is good news from the US | [Source Link](https://news.google.com/rss/articles/CBMi3gFBVV95cUxQSXpwVlF1MUpEWENEeExnRm9XcmZoWGtTaU1CeFZUYVNNNk9ZU1dRTkcwQ1U3X18ya2V4c0pfbXYzaGhOQkpoTUtIMElySFlSVE1UNVhUaU10cjhGYTVRZlVlTlNGSmxKelJvUW5JTUpLQ1FOUUctVEVNcVJSQm1NMWZqNXdKcTA1bERNMlJrVFZVUXYycmtvSTNOa01CN3ByQTI0ZHpBYzNRM0NtMVFWeFdhR1d1S0lBaVh4TVVFT3A2YTl0d2VsMU5XVWp5Z29GUzNKVzBYN1B6a0F6dEHSAeMBQVVfeXFMTkhZYjhmRW5JZXA3T1ZaSFlDR3Z4SGd5ZG9kUEE2cWVkc3dNd3FaNlBEZFNNMF84YmtUdkxSeXBUMEN5LS1tTExJTjdPaXU0UHRENGhGdXQxcWFvYXpyc19kMk1RZHhaQ3YyV1VaejFCZWN4UjV) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-15/struggling-with-stubborn-cholesterol-there-is-good-news-from-the-us*
